Publication:
Efficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869

dc.contributor.authorVenkatarayana, Gangarapu
dc.contributor.authorİNCE, ALİ TÜZÜN
dc.contributor.authorİNCE, ALİ TÜZÜN
dc.contributor.authorKAYAR, YUSUF
dc.contributor.authorHakan, Şentürk
dc.contributor.authorŞENTÜRK, HAKAN
dc.contributor.authorGÖK, ÖZLEM
dc.contributor.authorUYSAL, ÖMER
dc.contributor.authorUYSAL, ÖMER
dc.date.accessioned2020-01-16T21:00:39Z
dc.date.available2020-01-16T21:00:39Z
dc.date.issued2015-05-15T00:00:00Z
dc.identifier.citationVenkatarayana G., İNCE A. T. , BAYSAL B., KAYAR Y., Hakan Ş., KILIÇ Ü., GÖK Ö., UYSAL Ö., -Efficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869-, Digestive Diseases Week 2015, Washington, Kiribati, 15 - 19 Mayıs 2015
dc.identifier.urihttps://openaccess.bezmialem.edu.tr/handle/20.500.12645/13337
dc.identifier.yoksis1511515
dc.titleEfficacy of Rifaximin on Circulating Endotoxins and Cytokines in Patients with Non Alcoholic Fatty Liver ID 2155869
dc.typeConference Paper
dspace.entity.typePublication
dspace.relatedentity.typePerson
dspace.relatedentity.typePerson
dspace.relatedentity.typePerson
local.avesis.idd02b2534-bfcb-4efe-8434-9055b8188aad
local.publication.isinternational1
person.identifier.orcid0000-0002-1627-4829
person.identifier.orcid0000-0002-2440-4478
relation.isAuthorOfPublication6daa6ab7-ee45-4f50-9e71-e831046b6462
relation.isAuthorOfPublication278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isAuthorOfPublication19df24c5-c3e8-4158-8eed-717f885c608d
relation.isAuthorOfPublication.latestForDiscovery278fcf63-3b92-4368-bff6-f140ebd9aeb3

Files